Cargando…
MeSHDD: Literature-based drug-drug similarity for drug repositioning
Objective: Drug repositioning is a promising methodology for reducing the cost and duration of the drug discovery pipeline. We sought to develop a computational repositioning method leveraging annotations in the literature, such as Medical Subject Heading (MeSH) terms. Methods: We developed software...
Autores principales: | Brown, Adam S, Patel, Chirag J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5391732/ https://www.ncbi.nlm.nih.gov/pubmed/27678460 http://dx.doi.org/10.1093/jamia/ocw142 |
Ejemplares similares
-
A standard database for drug repositioning
por: Brown, Adam S., et al.
Publicado: (2017) -
Leveraging Population‐Based Clinical Quantitative Phenotyping for Drug Repositioning
por: Brown, Adam S., et al.
Publicado: (2018) -
A review of validation strategies for computational drug repositioning
por: Brown, Adam S, et al.
Publicado: (2016) -
Clinical trials on drug repositioning for COVID-19 treatment
por: Rosa, Sandro G. Viveiros, et al.
Publicado: (2020) -
Guiding Drug Repositioning for Cancers Based on Drug Similarity Networks
por: Qin, Shimei, et al.
Publicado: (2023)